维普中文期刊产品整合服务
9篇 您的检索式:作者名="HERLING AW"
    题名 作者 年代 出处 被引量
1Alterations of carbohydrate and lipid intermediary metabolism during inhi-bition of glucose-6-phosphatnse in rats显示文摘Herling AW Burger H Schubert G 1999Eur J Pharmacol1999,386,1:1
2A review of the animal pharmacology of roxatidine acetate显示文摘SCHOLTHOLT J BICKEL M HERLING AW 1988Drugs1988,35,3:1
3Pharmacolog-\ical profile of lixisenatide, a new GLP-1 receptor agonist for the treatment of type 2 diabetes显示文摘Werner U Haschke G Herling AW 2010Regul Pept2010,164,:1
4Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant显示文摘Herling AW Kilp S Juretschke H P 2008Int J Obes(Lond)2008,32,9:1
5Pharmacological profile of lixisenatide : a new GLP-1 receptor agonist for the treatment of type 2 diabetes显示文摘Werner U Haschke G Herling AW 2010Regul Peptides2010,164,2:1
6Pharmaco- logical profile of lixisenatide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes 显示文摘WERNER U HASCHKE G HERLING AW 2010Regul Pept2010,164,23:1
7Prolonged blood glucose reduction in MRP-2 deficient rats (GY/TR-) by the glucose-6-phosphate translocase inhibitor S 3025 显示文摘Herling AW Schwab D Burger HJ 2002Biochim Biophy Acta2002,1569,13:1
8CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats 显示文摘Herling AW Gossel M Haschke G 2007Am J Physiol Endocrinol Metab2007,293,3:1
9Pharma- cological profile of 显示文摘Werner U Haschke G Herling AW 2010Regul Pept2010,164,23:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费